Mar 6, 2026
Beijing | October 11, 2025
Akeso, a global leader in precision vision care and optical engineering, announced that its Founder and CEO, Dr. Xiaogu Cai, has been awarded the Emerging Distinguished Talent Award under the Jingxian Program 2.0. The honor was presented at the 2025 Jingxian Talent Conference, an international innovation forum focused on frontier technologies and next-generation healthcare solutions.
Held under the theme “Honoring Visionary Minds, Shaping the Future,” the event convened global experts in applied sciences, advanced manufacturing, and medical technology to spotlight transformative innovation across industries. Dr. Cai was recognized for his pioneering role in applying semiconductor-grade lithography to personalized myopia management and lens manufacturing.
At the conference’s innovation showcase, Akeso presented its MetaRx™-powered lens platform and precision myopia management ecosystem. The booth drew significant engagement from researchers, policymakers, and optical industry stakeholders, highlighting strong global interest in advanced approaches to myopia prevention and visual health.
Akeso’s MetaRx™ Lithography Technology is an optical breakthrough that brings semiconductor fabrication precision to the eyewear industry. With sub-50-nanometer structural fidelity, the technology achieves ultra-high overlay accuracy and enables unprecedented control over complex lens microstructures.
This innovation directly tackles core challenges in pediatric myopia management, including:
Dr. Cai has led Akeso’s scientific direction since its founding, leveraging over a decade of research in applied optics, optometry, and ophthalmic public health. He trained under Professor Wang Ningli, a world-renowned leader in ophthalmology, and contributed to one of the largest global epidemiological studies on eye disease.
Under Dr. Cai’s leadership, Akeso has secured more than 60 granted patents and introduced high-impact solutions that are actively reshaping the field of vision care.
“MetaRx™ lithography fundamentally redefines how lenses are designed,” said Dr. Cai during a live product demonstration. “When combined with AI-based visual modeling, it enables every lens to be custom-built for the patient’s specific needs.”
Akeso’s full-stack myopia management solutions showcased at the conference included:
Each product forms part of Akeso’s closed-loop vision health model, integrating prevention, control, and behavioral training to deliver measurable long-term outcomes in pediatric vision care.
The Jingxian Program 2.0 was launched to accelerate high-tech innovation in China through talent-focused policy frameworks. It fosters the integration of scientific research, education, and industrial application through events like the Jingxian Talent Conference.
According to government representatives, Dr. Cai’s selection reflects both individual scientific achievement and Akeso’s emergence as a globally relevant deep-tech enterprise in ophthalmic innovation.
Following this recognition, Akeso will continue to expand the global application of its MetaRx™ platform, transitioning vision technology from standardized manufacturing to truly personalized and intelligent optical engineering.
By merging AI, lithography, and clinical insight, Akeso is building the foundation for next-generation solutions that redefine how vision is corrected, protected, and enhanced.
Akeso Eyecare is a doctor-founded eye-technology company and CDMO focused on improving vision care. We design and build advanced solutions like AR displays for myopia prevention, eye tracking, extended reality devices, and digital vision health tools used in eye care and smart technology.
Our mission is to improve global vision health through smart innovation. By combining optical design, materials science, and AI, our R&D team supports partners from early research to custom design, manufacturing, and large-scale production, always guided by medical expertise, collaboration, sustainability, and patient-first thinking.
Akeso – engineering the future of vision.
Engineering the
Future of Vision.